The scholarly publishing landscape shifted this week as Wiley, the global research and education company listed on the New York Stock Exchange under the ticker WLY, announced the launch of two new open access journals: Advanced Medicine and Advanced Healthy Aging. Both titles are now accepting submissions and join a family of publications that has grown steadily throughout the year, bringing the Advanced Portfolio to more than thirty journals. The move signals a deliberate strategy by one of the world’s oldest publishing houses to stake out territory in some of the most consequential and fast-moving areas of biomedical research, from translational clinical science to the biology of why we age and how we might age better.
The new arrivals are not isolated launches. Earlier this year, Wiley introduced Advanced Oncology, Advanced Brain, and Advanced Immunology, and the cumulative effect of these additions is a portfolio that now reaches deep into medicine’s most active research frontiers. The Advanced Portfolio is anchored by two flagship titles that have shaped their fields for decades: Advanced Science, an interdisciplinary journal covering fundamental and applied research across the sciences, and Advanced Materials, one of the most recognized names in materials research worldwide. The portfolio’s editorial model, built on close collaboration between authors and editors, has been credited with earning the trust of the global research community over more than three decades, and the new medical titles are designed to carry that same philosophy into the life and health sciences.
Advanced Medicine enters a crowded field with a distinctive framing. The journal is described as broad-scope and open access, dedicated to publishing significant advances across medicine, and it adopts what Wiley calls a bench-to-bedside-to-population approach. That phrase captures an ambition to span the full arc of medical progress: discoveries made at the laboratory bench, translated into therapies and diagnostics tested at the bedside, and then evaluated at the level of entire populations through public health policy. In practice, the journal says it will bridge translational innovation, digital health, artificial intelligence-driven clinical intelligence, and population health policy, welcoming research that crosses the traditional boundaries between medical specialties.
That interdisciplinary posture matters at a time when the most consequential medical breakthroughs increasingly refuse to sit within a single discipline. Machine learning models that predict disease progression draw on computer science, clinical data curation, and epidemiology. Digital health tools blur the line between clinical intervention and consumer technology. Population-scale genomic studies require statisticians, clinicians, and ethicists to work in concert. By positioning itself as a venue for work that crosses these boundaries, Advanced Medicine is betting that researchers want a home that rewards integration rather than siloed specialization. The journal also states that it aims to foster dialogue between research scientists, clinicians, and public health leaders, supporting practices and policies that lead to measurable improvements in human health worldwide.
Leadership of the new journal reflects its translational orientation. Advanced Medicine is led by Editor-in-Chief Sui Seng Tee, who holds a Ph.D. in biochemistry from the University of Cambridge and brings experience in cancer metabolism, imaging, translational medicine, and interdisciplinary biomedical research, along with direct experience in scholarly publishing. Tee is supported by two Deputy Editors. Xiaoyu Zhang earned a Ph.D. in Biochemistry and Molecular Biology from East China Normal University and brings institutional knowledge and publishing experience along with broad interests across the life and health sciences. Alberto Oliveira Justo, whose work spans fundamental and translational science with interests in pharmacology, physiology, neurodegeneration, endothelial metabolism, and epidemiology, holds a Ph.D. from the University of Campinas. Together, the team’s expertise covers the spectrum from molecular mechanisms to population-level analysis.
The second launch, Advanced Healthy Aging, addresses what may be one of the most intellectually and commercially vibrant questions in contemporary bioscience: why do individuals age so differently, and can the science of aging be redirected toward extending health rather than merely prolonging life? The journal is described as an open access, interdisciplinary publication exploring the science of aging through resilience biology and lifecourse science, with an explicit mission to advance the science of healthspan, the portion of life spent in good health, and to understand heterogeneity in aging trajectories. Rather than focusing on late-stage disease, the journal concentrates on healthy aging trajectories, offering researchers a dedicated venue for work that integrates biology, life course exposures, and functional outcomes to advance precision approaches to aging.
The scientific scope of Advanced Healthy Aging is deliberately wide. The journal spans molecular and systems biology, clinical and translational interventions, population research, and public health. That breadth mirrors a real shift in geroscience, the interdisciplinary study of aging, where researchers increasingly argue that aging itself, rather than any single age-related disease, is the most promising target for intervention. Cellular senescence, mitochondrial dysfunction, proteostasis, and epigenetic drift are studied at the molecular level, while large cohort studies track how socioeconomic conditions, early-life exposures, and lifestyle factors shape trajectories of physical and cognitive function decades later. A journal that can connect these levels of analysis, from molecular pathways to population outcomes, addresses a genuine gap in how aging research is published and synthesized.
Advanced Healthy Aging is led by Editor-in-Chief Yixin Yao, whose background combines clinical medicine, biomedical research, scientific publishing, and healthcare leadership. Yao earned her medical degree from Shanghai Jiao Tong University School of Medicine and completed both her M.Sc. and Ph.D. in Environmental Health Sciences at New York University School of Medicine. Before joining Wiley in 2026, she held editorial roles at multiple leading journals. Her training in environmental health sciences is notable for a journal emphasizing lifecourse science, since environmental exposures across the lifespan are increasingly recognized as central determinants of how individuals age.
The strategic logic behind the launches was articulated by Allyn Molina, group vice president of publishing development at Wiley, who said that at its core the Advanced Portfolio is about offering opportunities for researchers to find the best home for their ground-breaking work. Molina noted that this year the company has introduced new journals spanning oncology, brain science, immunology, and now medicine and aging biology, each carrying the same editorial standards and author-first philosophy that researchers in the physical sciences have trusted for more than three decades. The portfolio’s editorial approach is designed to empower scientists and make publishing easier through a streamlined, collaborative process in which editors work closely with authors, a model that contrasts with the often adversarial dynamics associated with high-rejection flagship journals.
For the research community, the practical significance of the announcement lies in what the new journals choose to publish and how quickly that work becomes available. Both titles are fully open access, meaning accepted articles are free for anyone to read, a model that aligns with funder mandates and with the growing expectation that publicly supported health research should be publicly accessible. For clinicians and public health practitioners, open access removes paywalls that have historically slowed the flow of research findings into practice. For researchers in low- and middle-income countries, where much of the world’s population health burden is concentrated, unrestricted access to the latest advances in medicine and aging science can be transformative. More information about the Advanced Portfolio is available through Wiley Online Library. As the portfolio passes the thirty-journal mark, the question now facing the community is whether these new titles can convert Wiley’s established editorial reputation in the physical sciences into equivalent trust in medicine and aging biology, two fields where the stakes, and the potential rewards, could hardly be higher.
Subject of Research: Launch of two open access Wiley journals covering translational medicine and the interdisciplinary science of healthy aging
Article Title: Wiley launches two new research journals—Advanced Medicine and Advanced Healthy Aging—Continuing expansion of its Advanced Portfolio
Article References: Wiley launches two new research journals—Advanced Medicine and Advanced Healthy Aging—Continuing expansion of its Advanced Portfolio. (n.d.). Original publication
Image Credits: AI Generated
DOI: Not provided
Keywords: Wiley, Advanced Medicine, Advanced Healthy Aging, open access, scholarly publishing, Advanced Portfolio, translational medicine, aging research, healthspan, digital health, population health, Editor-in-Chief
News Source: Beatrice Stafford. (October 13, 2026). Wiley Expands Advanced Portfolio with Two New Open Access Journals in Medicine and Healthy Aging. Scienmag.
